Cancer Research

The long-standing wall between the mind and the body is finally crumbling as genetic research reveals a deeply integrated biological reality. Ivan Kairatov, a biopharma expert with a distinguished background in research and development, has spent his career at the forefront of pharmaceutical

In the landscape of biopharmaceutical innovation, Ivan Kairatov stands as a prominent figure whose work bridges the gap between high-throughput technology and therapeutic application. With a career rooted in deep-tier research and development, Kairatov has dedicated years to understanding how

The long-standing pursuit of a "magic bullet" in oncology has frequently been thwarted by the elusive nature of tumor suppressors, which are genetic elements that are not there to be blocked, but rather are missing entirely. Traditional pharmacology excels at inhibiting overactive proteins, yet it

The struggle against lung cancer has long been complicated by a secondary, equally lethal condition known as muscle wasting or cachexia, which drains a patient’s strength and accounts for nearly thirty percent of oncology-related deaths. Lung cancer remains a primary driver of mortality in the

Domestic felines share more than just a home with their owners; they reside in a mirrorspace of biological risks where identical environmental stressors trigger remarkably similar oncological outcomes. This proximity has long been observed by veterinarians, but recent genomic mapping has finally

The long-standing scientific pursuit of understanding chronic illness has traditionally centered on the intricate mapping of the human genome to find the origins of our most persistent ailments. For several decades, researchers operated under the assumption that the answers to cardiovascular